Can inhalation agents be used in the presence of a child with myopathy?

Current Opinion in Anaesthesiology

Volumn 23, Issue 3, 2010, Pages 348-355

  Veyckemans, Francis ^a  

^a Katholieke Universiteit Brussel   (Belgium)

Author keywords

Halogenated agent; Malignant hyperthermia; Myopathy; Paediatric; Rhabdomyolysis

Indexed keywords

ADENOSINE MONOPHOSPHATE DEAMINASE; ALPHA7 INTEGRIN; CARNITINE; COLLAGEN TYPE 6; DYSTROPHIN; FUKUTIN; INHALATION ANESTHETIC AGENT; KETAMINE; LAMININ ALPHA2; PROPOFOL; SUXAMETHONIUM;

BECKER MUSCULAR DYSTROPHY; CENTRAL CORE DISEASE; CENTRONUCLEAR MYOPATHY; CHILD; CREATINE KINASE BLOOD LEVEL; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG CHOICE; DUCHENNE MUSCULAR DYSTROPHY; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FAMILY HISTORY; GLYCOGEN STORAGE DISEASE TYPE 5; HIGH RISK PATIENT; HUMAN; HYPERMETABOLISM; INHALATION ANESTHESIA; LACTATE BLOOD LEVEL; LIMB GIRDLE MUSCULAR DYSTROPHY; MALIGNANT HYPERTHERMIA; MULTIMINICORE DISEASE; MUSCLE BIOPSY; MYOFIBROSIS; MYOPATHY; MYOTONIC DYSTROPHY; NEMALINE MYOPATHY; OCULOPHARYNGEAL MUSCULAR DYSTROPHY; PERIODIC PARALYSIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROPOFOL INFUSION SYNDROME; REVIEW; RHABDOMYOLYSIS; RISK BENEFIT ANALYSIS; SCHWARTZ JAMPEL SYNDROME; THOMSEN DISEASE;

ANESTHESIA, INHALATION; CHILD, PRESCHOOL; GLYCOGEN STORAGE DISEASE TYPE V; HUMANS; INFANT; MALIGNANT HYPERTHERMIA; MUSCULAR DISEASES; MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL; MYOPATHY, CENTRAL CORE; MYOTONIC DYSTROPHY; RHABDOMYOLYSIS;

EID: 77951984766     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/ACO.0b013e3283393977     Document Type: Review

References (39)

1. Litman RS, Rosenberg H. Malignant hyperthermia-associated diseases: state of the art uncertainty (editorial). Anesth Analg 2009; 109: 1004-1005.
2. Litman RS. MH-associated diseases: who really needs a nontriggering technique? Semin Anesth Perioperat Med Pain 2007; 26: 113-119.
3. Davis PJ, Brandom BW. The association of malignant hyperthermia and unusual disease: when you're hot you're hot or maybe not (editorial). Anesth Analg 2009; 109: 1001-1003.
4. Hayes J, Veyckemans F, Bissonnette B. Duchenne muscular dystrophy: an old anesthesia problem revisited. Pediatr Anesth 2008; 18: 100-106.
5. Flick RP, Gleich SJ, Herr M M H, Wedel DJ. The risk of malignant hyperthermia in children undergoing muscle biopsy for suspected neuromuscular disorder. Pediatr Anesth 2007; 17: 22-27.
6. Driessen JJ, Willems S, Dercksen S, et al. Anesthesia-related morbidity and mortality after surgery for muscle biopsy in children with mitochondrial defects. Pediatr Anesth 2007; 17: 16-21.
7. Phadke A, Broadman LM, Brandom BW, et al. Postoperative hyperthermia, rhabdomyolysis, critical temperature, and death in a former premature infant after his ninth general anesthetic. Anesth Analg 2007; 105: 977-980.
8. Muntoni F, Voit T. The congenital muscular dystrophies in 2004: a century of exciting progress. Neuromuscul Disord 2004; 14: 635-649.
9. Cohn RD, Campbell KP. Molecular basis of muscular dystrophies. Muscle Nerve 2000; 23: 1456-1471.
10. Deconinck N, Dan B. Pathophysiology of Duchenne muscular dystrophy: current hypotheses. Pediatr Neurol 2007; 36: 1-7.
11. Aldwinckle RJ, Carr AS. The anesthetic management of a patient with Emery-Dreifuss muscular dystrophy for orthopedic surgery. Can J Anaesth 2002; 49: 467-470.
12. Gurnaney H, Brown A, Litman RS. Malignant hyperthermia and muscular •• dystrophies. Anesth Analg 2009; 109: 1043-1048. Extensive review of the literature and practical considerations on how to manage a child with a (possible) muscular dystrophy.
13. Moro C, Dangelser G, Veyckemans F. Prise en charge anesthésique d'un enfant atteint de delta-sarcoglycanopathie. Ann Fr Anesth Réanim 2007; 26: 359-362.
14. Ross AK. Muscular dystrophy versus mitochondrial myopathy: the dilemma of the undiagnosed hypotonic child (editorial). Pediatr Anesth 2007; 17: 1-6.
15. Nakazato A, Shime H, Morooka K, Nonaka I. Anesthesia-induced rhabdomyolysis in a patient with Fukuyama type congenital muscular dystrophy. Brain Dev 1983; 5: 243.
16. Shukry M, Guruli ZV, Ramadhyani U. Suspected malignant hyperthermia in a child with laminin 2 (merosin) deficiency in the absence of triggering agents. Pediatr Anesth 2006; 16: 462-465.
17. Gropp A, Kern C, Frei FJ. Anaesthetic management of a child with muscle-eyebrain disease. Paediatr Anaesth 1994; 4: 197-200.
18. Sahajananda H, Meneges J. Anaesthesia for a child with Walker-Warburg syndrome. Paediatr Anaesth 2003; 13: 624-628.
19. Costi D, Van Der Walt JH. General anesthesia in an infant with X-linked myotubular myopathy. Pediatr Anesth 2004; 14: 964-968.
20. Quin RD, Pae WE, McGarry SA, Wickey GS. Development of malignant hyperthermia during mitral valve replacement. Ann Thorac Surg 1992; 53: 1114-1116.
21. Klingler W, Rueffert H, Lehmann-Horn F, et al. Core myopathies and risk of •• malignant hyperthermia. Anesth Analg 2009; 109: 1167-1173. Review of the possible association of malignant hyperthermia with muscle diseases with similar histology but different gene mutations.
22. Parness J, Bandschapp O, Girard T. The myotonias and susceptibility to •• malignant hyperthermia. Anesth Analg 2009; 109: 1054-1064. The possible anaesthetic problems of these diseases are reviewed starting with a description of the ion channels involved.
23. Farbu E, Softeland E, Bindoff LA. Anaesthetic complications associated with myotonia congenita: case study and comparison with other myotonic disorders. Acta Anaesthesiol Scand 2003; 47: 630-634.
24. Haberer JP, Fabre F, Rose E. Malignant hyperthermia and myotonia congenita (Thomsen's disease) (letter). Anaesthesia 1989; 44: 166.
25. Ray S, Rubin P. Anaesthesia in a child with Schwartz Jampel syndrome. Anaesthesia 1994; 49: 600-602.
26. Benca J, Hogan K. Malignant hyperthermia, coexisting disorders, and enzymo-•• pathies: risks and management options. Anesth Analg 2009; 109: 1049-1053. Summary of what we know about some rare diseases and their possible genetic or pathophysiological link with malignant hyperthermia.
27. Maharaj R, Osborne I J S. The King-Denborough syndrome in the paediatric patient. S Afr J Anaesth Analg 2007; 13: 27-30.
28. Muravchick S, Levy RJ. Clinical implications of mitochondrial dysfunction. Anesthesiology 2006; 105: 819-837.
29. Footitt EJ, Sinha MD, Raiman J A J, et al. Mitochondrial disorders and general •• anaesthesia: a case series and review. Br J Anaesth 2008; 100: 436-441. Up-to-date review of anaesthesia in patients with a mitochondrial disorder based on the authors' experience and data from the literature.
30. Ohtani Y, Mike T, Ishitsu T, et al. A case of malignant hyperthermia with mitochondrial dysfunction. Brain Dev 1985; 7: 249.
31. Fricker RM, Raffelsberger T, Rauch-Shorny S, et al. Positive malignant hyperthermia susceptibility in vitro test in a patient with mitochondrial myopathy and myoadenylate deaminase deficiency. Anesthesiology 2002; 97: 1635-1637.
32. Baumeister FA, Oberhoffer R, Liebhaber GM. Fatal propofol infusion syndrome in association with ketogenic diet. Neuropaediatrics 2004; 35: 250-252.
33. Hogan KJ, Vladutiu GD. Malignant hyperthermia-like syndrome and carnitine palmitoyltransferase II deficiency with heterozygous R503C mutation. Anesth Analg 2009; 109: 1070-1072.
34. Katsuya H, Msumi M, Ohtan Y, et al. Postanesthetic anuric renal failure due to carnitine palmitoyl transferase deficiency. Anesthesiology 1988; 68: 945-948.
35. Lobato EB, Javelle GM, Urdaneta F, Malias MA. Non cardiogenic pulmonary edema and rhabdomyolysis after protamine administration in a patient with unrecognized McArdle's disease. Anesthesiology 1999; 91: 303-305.
36. Bollig G, Mohr S, Raeder J. McArdle's disease and anaesthesia: case reports. Review of potential problems and association with malignant hyperthermia. Acta Anaesthesiol Scand 2005; 49: 1077-1083.
37. Lambert C, Blanloeil Y, Krivosic-Horber R, et al. Malignant hyperthermia in a patient with hypokaliemic periodic paralysis. Anesth Analg 1994; 79: 1012-1014.
38. Gunter JB, Ball AS, Than-Win S. Preparation of the Drager Fabius anesthesia machine for the malignant-hyperthermia susceptible patient. Anesth Analg 2008; 107: 1936-1945.
39. Ciafaloni E, Fox DJ, Pandya S, et al. Delayed diagnosis in Duchenne muscular dystrophy: data from the muscular dystrophy surveillance, tracking and research network. J Pediatr 2009; 155: 380-385.